ASX:PYC - PYC Therapeutics Ltd - a unique opportunity?
PYC- PYC is dedicated to changing the lives of patients with rare genetic diseases – a unique opportunity in drug development
- Very powerful rounding bottom formation, manage the multiyear high and closed above that.
- Manage to close above the Jan 2010 high, close to 127 months.
- Given the massive run close to 3X in last one year.
- Downside - Volumes are still lower side
- Previously called Phylogica Limited (PYC), 27/11/2019 ( I generally don't like a company that changes name, just difficult to track)
- Disc: Invested ( Tracking position, Trade @ own RISK. Education purpose only. Risk Management is the key.
- Check out the investor's presentation for more details
https://newswire.iguana2.com/af5f4d73c1a54a33/pyc.asx/6A983281/PYC_Investor_Presentation_June_2020
Dagangan aktif
ASX closed flat for the week. Stock down 11.5% for the week. Volumes for the week are below average. My Stop loss still intact. Close below .100 WCB
Nota
Up over 8% today. Let see if stock ready for new journey up.
Join me on Twitter @bhatiashivendra to stay updated on my thoughts and insights on stocks, financial assets, and markets. I focus on research-based analysis and avoid hype. As an experienced investor in a diverse range of assets, I invite you to conduct
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.
Join me on Twitter @bhatiashivendra to stay updated on my thoughts and insights on stocks, financial assets, and markets. I focus on research-based analysis and avoid hype. As an experienced investor in a diverse range of assets, I invite you to conduct
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.